Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Non-Hodgkin 17Dendritic Cell Sarcoma, Interdigitating 17Multiple Myeloma 16Lymphoma, Mantle-Cell 16Lymphoma, Large-Cell, Immunoblastic 16Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Follicular 16Lymphoma, B-Cell, Marginal Zone 16Leukemia, Myeloid, Acute 16Leukemia, Lymphocytic, Chronic, B-Cell 16Hodgkin Disease 16Burkitt Lymphoma 16Recurrence 14Myelodysplastic Syndromes 14Myeloproliferative Disorders 13Congenital Abnormalities 13Neoplasms, Plasma Cell 12Lymphoma 12Leukemia, Myeloid, Accelerated Phase 12Leukemia 12Primary Myelofibrosis 10Leukemia, Myeloid, Chronic-Phase 10Blast Crisis 10Sezary Syndrome 9Mycosis Fungoides 9Lymphoma, T-Cell, Cutaneous 9Leukemia, Myelomonocytic, Juvenile 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Waldenstrom Macroglobulinemia 8

Interventions

Doxorubicin 142Ifosfamide 85Radiotherapy 82Cyclophosphamide 72Gemcitabine 63Filgrastim 54pembrolizumab 43pazopanib 40Etoposide 39Docetaxel 39Vincristine 37Trabectedin 37Cisplatin 35Nivolumab 32Magnetic Resonance Spectroscopy 26Irinotecan 26Carboplatin 25Surgical Procedures, Operative 24Temozolomide 23Radiation 22Ipilimumab 22Bevacizumab 20Blood Specimen Collection 19Granulocyte Colony-Stimulating Factor 18Biopsy 18eribulin 17anlotinib 17Sirolimus 17Mesna 17Melphalan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Tacrolimus × Sarcoma × Clear all
NCT00043979 2017-05-31

Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
60 enrolled 31 charts
Sarcoma

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡